Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population

BACKGROUND: Cumulative evidence in colorectal cancer (CRC) suggests that patients with human epidermal growth factor receptor 2 (HER2) overexpression or amplification can benefit from anti-HER2 therapy. The purpose of our study was to evaluate HER2 status and its correlation with clinicopathological...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Shujuan, Wang, Xin, Chang, Jinjia, Sun, Hui, Weng, Weiwei, Wang, Xu, Tan, Cong, Zhang, Meng, Wang, Lei, Huang, Zhaohui, Huang, Dan, Xu, Midie, Sheng, Weiqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097912/
https://www.ncbi.nlm.nih.gov/pubmed/35574415
http://dx.doi.org/10.3389/fonc.2022.842787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097912/
https://www.ncbi.nlm.nih.gov/pubmed/35574415
http://dx.doi.org/10.3389/fonc.2022.842787

Ejemplares similares